SCHEMBL17367113

SCHEMBL17367113

c1ccc2cc(-n3c4ccccc4c4cc5sc6sc7ccccc7c6c5cc43)ccc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PMM2 O15305 1/20 0.41
MPI P34949 1/20 0.41
PHOSPHO1 Q8TCT1 1/20 0.41
KDM4E B2RXH2 1/20 0.34
ATM Q13315 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
HPGD P15428 1/20 0.33
F2 P00734 1/20 0.32
F10 P00742 1/20 0.32
PRSS1 P07477 1/20 0.32
MAPT P10636 1/20 0.32
MAPK10 P53779 3/20 0.32
MAPK9 P45984 2/20 0.32
HTR3A P46098 1/20 0.31
NPC1 O15118 1/20 0.31
ALDH1A1 P00352 1/20 0.31
POLB P06746 1/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
RPA1 P27694 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17367099 0.95 PMM2 (0.39) PMM2MPIPHOSPHO1KDM4EATM
SCHEMBL10014584 0.87 PMM2 (0.45) PMM2MPIPHOSPHO1KDM4EATM
SCHEMBL17367070 0.85 PMM2 (0.43) PMM2MPIPHOSPHO1KDM4EATM
SCHEMBL15101941 0.83 KDM4E (0.41) KDM4EATML3MBTL1
SCHEMBL15180611 0.83 KDM4E (0.43) KDM4EATML3MBTL1HPGDMAPT
SCHEMBL10014524 0.82 PMM2 (0.42) PMM2MPIPHOSPHO1KDM4EATM
SCHEMBL17367132 0.82 KDM4E (0.43) PMM2MPIPHOSPHO1KDM4EATM
SCHEMBL17367123 0.82 PMM2 (0.38) PMM2MPIPHOSPHO1KDM4EATM
SCHEMBL17367105 0.82 PMM2 (0.38) PMM2MPIPHOSPHO1KDM4EATM
SCHEMBL17299993 0.82 ATM (0.43) PMM2MPIPHOSPHO1KDM4EATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10749118-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-08-18 US disclosed
US-20150380663-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-12-31 US disclosed
US-20150380663-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150380663-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CYP1A1, CRY1, CYP1B1 PMM2 4227/4885MPI 3400/4885PHOSPHO1 4069/4885
US-10749118-B2 Heterocyclic compound and organic light-emitting device including the same CYP1A1, CRY1, CYP1B1 PMM2 4227/4885MPI 3400/4885PHOSPHO1 4069/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.